Technology

Quest Launches Consumer-Initiated Genetic Test on questhealth.com to Deliver Personalized, Actionable Health Risk Insights

Published

3 years ago

July 11, 2023

First consumer genetic health test under the Quest brand provides insights based on DNA, with unique features that include next-generation sequencing, robust support services, physician ordering, and access to one-on-one genetic counseling

SECAUCUS, N.J., July 11, 2023 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today announced the launch of its first consumer-initiated genetic test, now exclusively available through the company’s consumer health business at questhealth.com. Called Genetic Insights, the new offering helps people understand their potential risk of developing certain inheritable health conditions, with advanced technology and end-to-end support that includes personalized health reports and access to genetic counseling.

Using a saliva specimen, Genetic Insights analyzes 36 genes to identify potential risk of nearly two dozen inheritable conditions, including breast and colon cancer; a number of heart and blood disorders; and carrier status for cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. Designed to address gaps in existing consumer genetic tests, the new test is powered by advanced next-generation sequencing (NGS) technology*, which can analyze thousands of DNA variants in genes associated with disease and looks at more regions in a person’s genome than microarray testing technology.

“Genetic Insights goes beyond the typical consumer genetic test. The Quest team spent the past couple of years innovating not just the test, but the entire consumer experience to deliver comprehensive, complex genetic health data in a way that is digestible and actionable to the end user,” said Dr. Sarah South, PhD, FACMG, Executive Scientific Director of R&D for Molecular Genetics and Oncology, Quest Diagnostics. “The use of NGS is a crucial distinction, because NGS-based tests are uniquely able to identify a wider range of genetic conditions and keep pace with new genetic discoveries.”

A uniquely guided user experience
Individuals who purchase Genetic Insights at questhealth.com will receive an at-home saliva-collection kit and ship back their sample to Quest Diagnostics for analysis in one of the company’s state-of-the-art laboratories. An independent physician orders the test for the individual, provides personalized information about the link between the genetic findings and the individual’s health status, and is available to discuss the individual’s questions. Test results will be available within three to five weeks.

Each kit includes an activation code to unlock access to a personalized, secure interactive Genetic Insights online dashboard, where users can:

Gain an overview of the Genetic Insights experience and access easy-to-understand educational materials on various conditions for which there could be risk;Provide relevant personal and family health history via a secure questionnaire, supporting results interpretation by the ordering physician;Track the status of each test kit, from sample collection to testing to results delivery;Chart family health history via an easy-to-use template that can be downloaded and shared with the individual’s doctor;Access highly visual, personalized genetic health reports designed to break down complex genetic information into a digestible, actionable format. Reports include information on genes tested, test limitations, key takeaways, and suggested next steps based on DNA and family history;Schedule a one-on-one phone or video session with a third-party board-certified genetic counselor—available at no extra charge—to discuss results and what they mean, address any questions, and help map next steps.

Supporting the continuity of care
To support a dialogue about inherited health risks and action steps, Genetic Insights also allows individuals to download and share clinical lab reports directly with their own doctors. Within the lab report, healthcare providers can access quick reference guides, which are intended to help facilitate discussions between providers and their patients and include key lab findings and clinical guideline-based resources and recommendations.

“Half the physicians in the U.S. trust Quest for their laboratory tests, so we added unique features, like physician reference guides, to support dialogue and continuity of care between individuals who order Genetic Insights and their providers,” Dr. South said. “We also wanted to ensure access to genetic counseling and easy-to-understand educational content, so people have the end-to-end support to understand and act on their personal health risks.”

Genetic Insights is now available for adults (ages 18+) in the United States** to purchase on questhealth.com for $199.

For more information, visit questhealth.com and follow @testwithquest on Instagram, Facebook, and Twitter.

*The Genetic Insights test is based on advanced NGS technologies that can detect 80-90 percent of inherited risk for specific health conditions1, including at least 80 percent of DNA variants linked to a higher risk of developing the most common form of inherited breast cancer. However, it is designed to be an elective screen and is not as sensitive as other NGS-based genetic test services that physicians may order in situations that require diagnostic-level sensitivity. Based on the results of this test and personal or family health history, an individual’s physician may suggest additional genetic testing. The Genetics Insights test does not identify genetic risk markers of all known inheritable diseases.

**Excludes AK, AZ, HI, and NY

About Quest
Quest empowers consumers by making affordable, high-quality, trusted healthcare easy. With innovative tools, we give consumers more control over their own healthcare journeys and meet them where they are, supporting both consumers and their care teams. Our consumer-initiated test service allows people access to the same quality lab tests used by doctors and hospitals, providing the information and insights they need about their health. With more than 75+ lab tests available at questhealth.com, from general health profiles to tests for conditions ranging from heart health to sexually transmitted diseases, consumers can shop, schedule test appointments, and access results securely from a phone or computer.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.

1 BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-launches-consumer-initiated-genetic-test-on-questhealthcom-to-deliver-personalized-actionable-health-risk-insights-301873616.html

SOURCE Quest Diagnostics

Technology

Greenzie releases 2025 Annual Safety Report, documenting multi-year safety performance at commercial scale

Published

1 hour ago

April 23, 2026

The data shows zero lost-time injuries, zero OSHA medical attentions and zero human near-misses across real-world operation

ATLANTA, April 23, 2026 /PRNewswire/ — Greenzie, the technology platform powering commercial autonomy across multiple OEMs, today shared multi-year safety data from real-world commercial operation, documenting more than 150,000 autonomous miles with zero lost-time injuries, zero OSHA medical attentions and zero human near-misses. The data is published in Greenzie’s 2025 Annual Safety Report, available at greenzie.com/safety.

The report is based on extensive operational data spanning more than 5.4 billion square feet of turf mowed, 68,000+ hours of autonomous mowing and more than 50,000 operator days, the equivalent of 265 mowing seasons.

“Greenzie is helping define safety in autonomous landscape operations, and transparency is a critical part of that,” said Steve Bush, chief operating officer of Greenzie. “These results show that commercial autonomy is operating safely at meaningful scale in the field. Transparency matters because as this category matures, real-world data helps build confidence in what responsible deployment looks like.”

The report’s findings are particularly significant in the context of the U.S. landscaping industry, which employs roughly 1.3 million workers and experiences a higher-than-average rate of workplace accidents compared to other fields. Greenzie’s multi-year operating data shows that autonomy is not theoretical; it is already being deployed consistently and performing safely at scale.

“Greenzie Powered Autonomy™ has been validated through years of sustained use in the field,” Bush said. “That level of real-world performance reinforces both the reliability of our platform and the broader readiness of commercial autonomy.”

Greenzie attributes this performance to a disciplined safety approach that includes robust perception, tested operating standards and continuous validation in real-world commercial environments.

For more information about Greenzie, visit greenzie.com.

About Greenzie

Founded in 2018, Greenzie is the technology platform powering commercial autonomy. Created to solve the landscape industry’s labor and productivity challenges, Greenzie works with leading equipment manufacturers to deliver the software, navigation and safety systems that enable mowing and other outdoor power equipment to operate autonomously in real-world commercial environments. Today, Greenzie’s platform is running on hundreds of machines in active use, helping manufacturers bring autonomy to market and allowing operators to get more done with limited labor—moving autonomy from early experimentation to everyday operations. For more information, visit greenzie.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/greenzie-releases-2025-annual-safety-report-documenting-multi-year-safety-performance-at-commercial-scale-302750335.html

SOURCE Greenzie

Technology

CGI renews global SAP S/4HANA operations and SAP BTP operations certifications, reinforcing its consistent, quality delivery at scale

Published

1 hour ago

April 23, 2026

Stock Market Symbols
GIB.A (TSX)
GIB (NYSE)
cgi.com/newsroom

MONTRÉAL, April 23, 2026 /CNW/ – CGI (NYSE: GIB) (TSX: GIB.A), one of the largest independent IT and business consulting services firms in the world, announced that it has achieved the following recertifications for its global operation capabilities:

SAP S/4HANA operations and works with RISE with SAP SAP BTP operations and works with RISE with SAP

These recertifications highlight CGI’s ability to deliver consistent, high-quality managed SAP services and operations across regions, including services aligned with RISE with SAP. CGI’s SAP-based services help clients reduce operational risk, improve performance and efficiency and scale transformation with greater predictability. This also builds on CGI’s SAP alliance relationship momentum, including its recent AWS SAP Competency Partner status which highlights CGI’s expertise in modernizing mission-critical SAP workloads with AI-enabled cloud solutions.

“Running SAP at enterprise scale requires a partner with proven capabilities, delivery discipline and the ability to innovate securely, including through the integration of AI to deliver tangible outcomes,” said Didier Thérond, President, CGI France operations, and Global Executive Sponsor for CGI’s partnership with SAP. “These global recertifications reinforce CGI’s end-to-end SAP capabilities, including AI-enabled services, helping clients operate mission-critical systems with confidence and advance their modernization and cloud strategies.”

“CGI remains a trusted partner in our SAP Operations Partner program, consistently demonstrating a structured and disciplined approach to certification,” said Rudolf Scheipers, VP, Head of SAP Operations Partner Certification, SAP Partner Innovation Lifecycle Services. “These recertifications highlight the company’s mature operating model and commitment to the high standards we expect globally, ensuring clients running SAP environments can rely on consistent, secure, and efficient operations.”

CGI’s global alliance strategy features partnerships with more than 150 technology companies and supports its local relationship model complemented by a global delivery network. Through its SAP alliance, CGI helps organizations accelerate innovation, deploy and manage SAP solutions globally, and deliver industry-specific business outcomes with rapid, scalable, and AI-enabled cloud and ERP services.

About CGI
Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 94,000 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2025 reported revenue is CA$15.91 billion and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at cgi.com.

View original content:https://www.prnewswire.com/news-releases/cgi-renews-global-sap-s4hana-operations-and-sap-btp-operations-certifications-reinforcing-its-consistent-quality-delivery-at-scale-302750863.html

SOURCE CGI Inc.

Technology

Scholastic Corporation Announces Final Results of Modified Dutch Auction Tender Offer

Published

1 hour ago

April 23, 2026

NEW YORK, April 23, 2026 /PRNewswire/ — Scholastic Corporation (the “Company” or “Scholastic”) (Nasdaq: SCHL), the global children’s publishing, education and media company, today announced the final results of its “modified Dutch Auction” tender offer for shares of its common stock, which expired at 5:00 p.m., New York City time, on April 20, 2026.

Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer, a total of 2,834,018 shares of Scholastic’s common stock, par value $0.01 per share (each share of Scholastic’s common stock, a “Share,” and collectively, “Shares”), were properly tendered and not properly withdrawn at or below the purchase price of $40.00 per Share, including 989,343 Shares that were tendered by notice of guaranteed delivery.

Scholastic has accepted for purchase a total of 2,834,018 Shares through the tender offer at a price of $40.00 per Share, for an aggregate cost of $113,360,720.00, excluding fees and expenses relating to the tender offer. The total of 2,834,018 Shares that Scholastic has accepted for purchase represents approximately 13.7% of the total number of Shares outstanding as of April 19, 2026.

J.P. Morgan Securities LLC served as the dealer manager for the tender offer. Georgeson LLC served as the information agent. Holders of common stock who have questions or need information about the tender offer may call Georgeson LLC at (866) 539-9980 (toll free). Banks and brokers may call Georgeson at (866) 539-9980 or J.P. Morgan Securities LLC at (877) 371-5947 (toll free).

About Scholastic

For more than 100 years, Scholastic Corporation (Nasdaq: SCHL) has been meeting children where they are – at school, at home and in their communities – by creating quality content and experiences, all beginning with literacy. Scholastic delivers stories, characters, and learning moments that empower all kids to become lifelong readers and learners through bestselling children’s books, literacy- and knowledge-building resources for schools including classroom magazines, and award-winning, entertaining children’s media. As the world’s largest publisher and distributor of children’s books through school-based book clubs and book fairs, classroom libraries, school and public libraries, retail, and online, and with a global reach into more than 135 countries, Scholastic encourages the personal and intellectual growth of all children, while nurturing a lifelong relationship with reading, themselves, and the world around them. Learn more at www.scholastic.com.

Forward-Looking Statements

This news release contains certain forward-looking statements. Such forward-looking statements are subject to various risks and uncertainties, including the conditions of the children’s book and educational materials markets generally and acceptance of the Company’s products within those markets, and other risks and factors identified from time to time in the Company’s filings with the Securities and Exchange Commission. Actual results could differ materially from those currently anticipated.

SCHL: Financial

View original content to download multimedia:https://www.prnewswire.com/news-releases/scholastic-corporation-announces-final-results-of-modified-dutch-auction-tender-offer-302751142.html

SOURCE Scholastic Corporation